Report Overview: The Global Biosimilars Market achieved a valuation of $35.14 Billion in 2022 and is anticipated to exceed $216.32 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 25.5% during the forecast period from 2024 to 2032. Key Market Players: F. Hoffmann-La Roche Ltd. (US), Sandoz International GmbH (Switzerland), Dr. Reddy’s Laboratories Ltd....